insights_auto
Why is OJU1 down 4.15%?
Dive Deeperchevron_right
OJU1:FRA
Oramed Pharmaceuticals, Inc.
€3.70
arrow_downward
-4.15%(-0.16) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OJU1...
Open
€3.70
High
€3.70
Low
€3.70
Mkt. cap
180.12M
Avg. vol.
83.00
Volume
0.00
52-wk high
€4.53
52-wk low
€1.88
No. of employees
13
Open
€3.70
High
€3.70
Low
€3.70
Mkt. cap
180.12M
Avg. vol.
83.00
Volume
0.00
52-wk high
€4.53
52-wk low
€1.88
No. of employees
13
News stories
From web sources and news partners
Simply Wall Street
·
26 minutes ago
Is ZoomInfo Technologies (GTM) Cheap As Its ClickUp Integration Sparks Fresh Interest?
MarketBeat
·
21 minutes ago
Eagle Financial Services Inc. (NASDAQ:EFSI) Stock Has Consensus Price Target of $43.75
AOL.com
·
58 minutes ago
Vanguard's S&P 500 Index Fund Charges About $3 a Year on $10,000. The Average Stock Fund Charges About $40.
Yahoo Finance
·
12 hours ago
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.